4-Week, Multiple-dose, Dose-escalating Study In Patients With Type 2 Diabetes
Clinical trial NCT03538743 · COMPLETED
Trial details
- NCT number
- NCT03538743
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-25
- Primary completion
- 2019-05-23
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.